Top Trends in Growth Hormone Deficiency outlook with industry review and forecasts 2026

Growth Hormone Deficiency

Summary 

GHD is an endocrine disorder characterized by the insufficient production of GH by the pituitary gland. GHD is more commonly seen in children, although it can develop during adulthood. GHD can be present from birth (congenital), or it can be secondary due to brain trauma (acquired). Generally, a child with GHD is born with normal size at birth, but has delayed rates of bone development and bone lengthening later on. Patients who acquire GHD later in life present with more generalized symptoms, such as increased abdominal fat, decreased levels of energy, and decrease in muscle mass. In young children, certain kinds of cancer treatments, such as cranial radiation, can increase the chances of developing GHD.

 Click here for sample report @ http://www.wiseguyreports.com/sample-request/1474114-epicast-report-growth-hormone-deficiency-epidemiology-forecast-to-2026

Report Highlights

This 10-year epidemiological forecast of GHD is supported by data obtained from international GHD disease monitoring databases, country-specific government sources, as well as peer reviewed studies using market-relevant disease definitions across the 7MM. This forecast provides detailed segmentations within GHD for each market by the patient’s age, sex, and etiological classification (congenital and idiopathic in children, and idiopathic and acquired in adults), thus creating a comprehensive view of the epidemiology of GHD in the 7MM. GlobalData epidemiologists maintained consistent forecast methodology across all seven markets, thus allowing for an accurate and meaningful comparison of included parameters among them.

 

Scope of the Report

 - The Growth Hormone Deficiency (GHD) EpiCast Report provides an overview of the risk factors, comorbidities, and global trends of GHD in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed prevalent cases of GHD in children (ages 18 years and younger) and adults (ages 19 years and older) segmented by age and sex. The diagnosed prevalent cases of GHD are further segmented into the classification of the disease (idiopathic and organic in children, and idiopathic and acquired in adults). Organic GHD in children is further segmented into congenital and acquired. GHD in adults is segmented by timing of disease onset: childhood onset GHD and adult onset GHD. 
- The GHD epidemiology report is written and developed by Masters- and PhD-level epidemiologists. 

  Table of Contents 

1 Table of Contents 2 
    1.1 List of Tables 3 
    1.2 List of Figures 3 
2 Executive Summary 4 
    2.1 Related Reports 5 
    2.2 Upcoming Reports 6 
3 Epidemiology 7 
    3.1 Disease Background 7 
    3.2 Risk Factors and Comorbidities 8 
    3.3 Global and Historical Trends 9 
      3.3.1 GHD in children 10 
      3.3.2 GHD in adults 11 
    3.4 Forecast Methodology 11 
      3.4.1 Sources 13 
      3.4.2 Forecast Assumptions and Methods 16 
    3.5 Epidemiological Forecast for GHD (2016-2026) 22 
      3.5.1 Diagnosed Prevalent Cases of GHD 22 
      3.5.2 Age-Specific Diagnosed Prevalent Cases of GHD 23 
      3.5.3 Sex-Specific Diagnosed Prevalent Cases of GHD 24 
      3.5.4 Idiopathic and Organic GHD in Children 25 
      3.5.5 Congenital and Acquired GHD Out of Organic GHD in Children 26 
      3.5.6 Idiopathic and Acquired GHD in Adults 27 
      3.5.7 Onset Timing 28  

 .Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1474114-epicast-report-growth-hormone-deficiency-epidemiology-forecast-to-2026

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.